Successful Treatment of Bowen’s Disease with Topical Maxacalcitol

Karashima, Tadashi; Hashikawa, Keiko; Ono, Fumitake; Eguchi, Hironobu; Hamada, Takahiro; Ishii, Norito; Dainichi, Teruki; Yasumoto, Shinichiro; Tsuruta, Daisuke; Hashimoto, Takashi

doi:10.2340/00015555-1294

Cited by 5 publications

(5 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These biological activities may also account for their effects against Kaposi's sarcoma (Masood et al, 2000) and Bowen's disease (Karashima et al, 2012). There has been no report suggesting the efficacy of vitamin D against PC.…”

Section: Discussionmentioning

confidence: 99%

“…The anti‐cancer actions of vitamin D have also been studied in breast, prostate, and colon cancers (Krishnan & Feldman, ). These biological activities may also account for their effects against Kaposi's sarcoma (Masood et al, ) and Bowen's disease (Karashima et al, ). There has been no report suggesting the efficacy of vitamin D against PC.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Successful treatment of porocarcinoma with maxacalcitol and imiquimod

Nagasawa

Hirata

Niiyama

et al. 2019

Dermatologic Therapy

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Successful treatment of porocarcinoma with maxacalcitol and imiquimod

Nagasawa

Hirata

Niiyama

et al. 2019

Dermatologic Therapy

View full text Add to dashboard Cite

show abstract

“…The nonconventional therapies such as a combination of oral cyclooxygenase enzyme inhibitor and topical imiquimod, topical tazarotene, topical diclofenac, topical maxacalcitol, phenol peel, topical and intralesional bleomycin, oral acitretin, oral isoretinoin with subcutaneous interferon-alpha and ultrasonic surgical aspiration have been useful. [ 2 9 19 24 89 100 ]…”

Section: Demographicsmentioning

confidence: 99%

Bowen's Disease

Palaniappan

Karthikeyan

2022

Indian Dermatology Online Journal

View full text Add to dashboard Cite

Bowen's disease (BD) is an in-situ squamous cell carcinoma of epidermis. The etiology of BD is multifactorial with high incidence among Caucasians. BD is common in photo-exposed areas of skin, but other sites can also be involved. Lesions are usually solitary. The morphology of BD differs based on age of the lesion, site of origin, and the degree of keratinization. BD is considered as the “lull before the storm,” which precedes an overt squamous cell carcinoma. Histopathology is the gold standard diagnostic modality to confirm the diagnosis. Immunohistochemistry, dermoscopy, and reflectance confocal microscopy are the adjuvant modalities used in the diagnosis of BD. The treatment depends on various factors like site, size, immune status, patient's age, esthetic outcome, etc. The available therapeutic modalities include topical chemotherapy, surgical modalities, light-based modalities, and destructive therapies. It requires a combined effort of dermatologist, oncosurgeon, and plastic surgeon to plan and execute the management in various presentations of BD.

show abstract

“…Other cutaneous neoplasms and dyskeratotic disorders reported to respond to calcipotriol or maxacalcitol include Bowen disease, 113 systematized epidermal nevus (combination calcipotriol/betamethasone diproprionate), 114 nevus comedonicus (combination of tazarotene and calcipotriol), 115,116 stucco keratosis, 117 and eruptive vellus hair cysts. 118 These all represent isolated case reports, and adequate assessment of therapeutic efficacy cannot be established in an evidence-based fashion.…”

Section: Other Cutaneous Neoplasmsmentioning

confidence: 99%